“…Hypoxia in chronic kidney disease ( Faivre et al, 2021 ; Wang B. et al, 2022 ) has been well studied and is used here to highlight the middle-aged (>50 years) ( Ryu et al, 2019 ) hypovascularity ( Fine and Norman, 2008 ; Evans et al, 2020 ; Querfeld et al, 2020 ) hypoxia ( Faivre et al, 2021 ; Wang L. et al, 2022 ) pathological trajectories in linking the endocrine system ( Zhao and Schooling, 2020 ; Li L. et al, 2022 ; Romejko et al, 2022 ), nitric oxide signaling, and oxygen homeostasis pathophysiology ( Burmakin et al, 2021 ; Carlström, 2021 ; Xu M. et al, 2022 ; Edwards and Kurtcuoglu, 2022 ). Oxidative stress–inflammation pathophysiology ( Ebert et al, 2021 ), amyloidosis ( Ryu et al, 2019 ; Herrera, 2021 ; Gurung and Li, 2022 ), autophagy ( Tang et al, 2020 ), and EMT ( Chen et al, 2022b ) would result in degenerative hypertrophy, fibrosis, atrophy, and neoplasm ( Ryu et al, 2019 ; Pinto et al, 2021 ) comorbid conditions ( Charles and Ferris, 2020 ).…”